These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10548275)

  • 1. The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat.
    Stromberg MF; Volpicelli JR; O'Brien CP; Mackler SA
    Pharmacol Biochem Behav; 1999 Nov; 64(3):585-90. PubMed ID: 10548275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal neurons against NMDA toxicity.
    Lin Y; Long JB
    Eur J Pharmacol; 1996 Dec; 318(2-3):491-6. PubMed ID: 9016943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
    Long JB; Skolnick P
    Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Aminocyclopropane-carboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo.
    Zapata A; Capdevila JL; Viu E; Trullas R
    Neuroreport; 1996 Jan; 7(2):397-400. PubMed ID: 8730790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex.
    Nowak G; Li Y; Paul IA
    J Neural Transm (Vienna); 2000; 107(2):123-31. PubMed ID: 10847554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NMDA glutamate receptor antagonist drugs on the volitional consumption of ethanol by a genetic drinking rat.
    McMillen BA; Joyner PW; Parmar CA; Tyer WE; Williams HL
    Brain Res Bull; 2004 Sep; 64(3):279-84. PubMed ID: 15464866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice.
    Przegaliński E; Siwanowicz J; Chojnacka-Wójcik E
    Pol J Pharmacol; 1999; 51(5):385-90. PubMed ID: 10817538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wojcik E
    Neuropharmacology; 1997 Jan; 36(1):31-7. PubMed ID: 9144639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of a glycine partial agonist alters the expression of N-methyl-D-aspartate receptor subunit mRNAs.
    Bovetto S; Boyer P; Skolnick P; Fossom LH
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1503-8. PubMed ID: 9400027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
    Peterson SL; Purvis RS; Griffith JW
    Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits.
    Sheinin A; Nahum-Levy R; Shavit S; Benveniste M
    Neurosci Lett; 2002 Jan; 317(2):77-80. PubMed ID: 11755244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat.
    Windisch KA; Czachowski CL
    Alcohol; 2018 Feb; 66():77-85. PubMed ID: 29220747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
    Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
    J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist.
    Papp M; Gruca P; Willner P
    Neuropsychopharmacology; 2002 Nov; 27(5):727-43. PubMed ID: 12431848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats.
    Popik P; Rygielska Z
    J Physiol Pharmacol; 1999 Mar; 50(1):139-51. PubMed ID: 10210162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.